|
TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2+ breast cancer |
|
|
|
Titel: |
TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2+ breast cancer |
Auteur: |
Shao, Xinyi Yang, Dawei Shan, Liuqun Yan, Xueqin Xu, Di Li, Lei Sun, Yidan Yu, Qiang Zhou, Honglei Ding, Yongbin Tang, Jinhai |
Verschenen in: |
Archives of toxicology |
Paginering: |
Jaargang 98 () nr. 3 pagina's 865-881 |
Jaar: |
2024-01-11 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|